Wire · opportunities
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 14 September 2026 · Fusion42 review
The FDA cleared the PrecivityAD2 blood test for diagnosing Alzheimer disease in adults aged 40 and older, offering a less invasive alternative to traditional diagnostic methods and enabling earlier detection and therapeutic decision-making.
This Wire brief sits within Fusion42's coverage of Digital Health, and 12 sources have reported it between 20 Aug 2026 and 14 Sep 2026.
◆ ◆ The Wire takeaway
Alzheimer diagnostics just turned more accessible and earlier by FDA clearing a blood test for 40-plus adults. You in digital health need to update clinical pathways and build on opening markets for earlier-stage care tools.
◆ Coverage
12 sources · first reported 20 Aug 2026 · latest 14 Sep 2026
◆ Related on Wire
◆ Topics